Does CRESTOR Cause Interstitial lung disease? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with CRESTOR. This represents 0.7% of all adverse event reports for CRESTOR.
8
Reports of Interstitial lung disease with CRESTOR
0.7%
of all CRESTOR reports
3
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From CRESTOR?
Of the 8 reports, 3 (37.5%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRESTOR. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CRESTOR Cause?
Type 2 diabetes mellitus (342)
Cardiovascular disorder (319)
Myocardial infarction (135)
Myalgia (87)
Drug dose omission (83)
Blood cholesterol increased (75)
Off label use (60)
Drug hypersensitivity (51)
Intentional product misuse (49)
Drug ineffective (48)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CRESTOR Alternatives Have Lower Interstitial lung disease Risk?
CRESTOR vs CRISABOROLE
CRESTOR vs CRIZANLIZUMAB
CRESTOR vs CRIZANLIZUMAB-TMCA
CRESTOR vs CRIZOTINIB
CRESTOR vs CROFELEMER